These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9637893)

  • 1. [A retrospective study on the development of inhibitors in Japanese hemophiliacs (second report, 1994 study). Research Group of Blood Products for Hemophilia Inhibitor].
    Kamiya T; Nagao T; Yoshioka A
    Rinsho Ketsueki; 1998 May; 39(5):402-4. PubMed ID: 9637893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study of inhibitor formation in Japanese hemophiliacs.
    Kamiya T; Takahashi I; Saito H
    Int J Hematol; 1995 Oct; 62(3):175-81. PubMed ID: 8589362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.
    von Auer Ch; Oldenburg J; von Depka M; Escuriola-Ettinghausen C; Kurnik K; Lenk H; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1051():498-505. PubMed ID: 16126990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].
    Honda K; Nagao T; Kamiya T; Yoshioka A; Miyazaki T; Takeda T; Mori K; Fukutake K; Hanabusa H; Taki M; Mohri H; Miyama J; Takamatsu J; Kinoshita S; Shirahata A
    Rinsho Ketsueki; 1998 Jun; 39(6):416-21. PubMed ID: 9695668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilia in Spain.
    Aznar JA; Lucía F; Abad-Franch L; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Parra R; Cortina VR
    Haemophilia; 2009 May; 15(3):665-75. PubMed ID: 19432921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of genetics in inhibitor formation.
    Gill JC
    Thromb Haemost; 1999 Aug; 82(2):500-4. PubMed ID: 10605742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited bleeding disorders: a 14-year retrospective study.
    Eid SS; Kamal NR; Shubeilat TS; Wael AG
    Clin Lab Sci; 2008; 21(4):210-4. PubMed ID: 19174980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Population and molecular-genetic aspects of hemophilia A and B in Uzbekistan].
    Boboev KT
    Tsitol Genet; 2008; 42(2):51-4. PubMed ID: 18630121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
    Astermark J; Oldenburg J; Escobar M; White GC; Berntorp E;
    Haematologica; 2005 Jul; 90(7):924-31. PubMed ID: 15996930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and utilization of hemophilia A and B patients with and without inhibitors.
    Armstrong EP; Malone DC; Krishnan S; Wessler MJ
    J Med Econ; 2014 Nov; 17(11):798-802. PubMed ID: 25111634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
    Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemophilia. Results of examination of 64 patients].
    Baklaja R; Ristić M; Rolović Z; Stefanović R; Stefanović S; Stojimirović E; Trajković P
    Srp Arh Celok Lek; 1966; 94(7):653-61. PubMed ID: 5986331
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course and treatment of hemophilia].
    István L
    Orv Hetil; 1971 Dec; 112(51):3055-62. PubMed ID: 5316391
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan.
    Tu TC; Liou WS; Chou TY; Lin TK; Lee CF; Chen JD; Cham TM; Chung MI
    Yonsei Med J; 2013 Jan; 54(1):71-80. PubMed ID: 23225801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
    Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
    Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
    Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.